Jean F. Voltaire

Array ( [id] => 11574582 [patent_doc_number] => 09629823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Composition for promoting collagen production, for promoting elastin production and/or for promoting keratinocyte migration and usage therefor' [patent_app_type] => utility [patent_app_number] => 14/902769 [patent_app_country] => US [patent_app_date] => 2014-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4401 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735926 [patent_doc_number] => 20140271638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF MANTLE CELL LYMPHOMAS' [patent_app_type] => utility [patent_app_number] => 14/291364 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12166 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719734 [patent_doc_number] => 20140255433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 14/281363 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19843 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806440 [patent_doc_number] => 20150018385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'FUSED AMINO PYRIDINES FOR THE TREATMENT OF BRAIN TUMORS' [patent_app_type] => utility [patent_app_number] => 14/274990 [patent_app_country] => US [patent_app_date] => 2014-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 20595 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14274990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12191724 [patent_doc_number] => 09895438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Treatment of cancer with naltrexone' [patent_app_type] => utility [patent_app_number] => 14/890300 [patent_app_country] => US [patent_app_date] => 2014-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5104 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12191634 [patent_doc_number] => 09895345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Use of Lappaol F to inhibit tumor cell growth' [patent_app_type] => utility [patent_app_number] => 14/889534 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 7049 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10076295 [patent_doc_number] => 09114130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Compounds and related methods for treatment of neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 14/271177 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4534 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9811968 [patent_doc_number] => 20150023914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'USE OF TELLURIUM COMPOUNDS FOR THE TREATMENT ACTINIC KERATOSIS' [patent_app_type] => utility [patent_app_number] => 14/257577 [patent_app_country] => US [patent_app_date] => 2014-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15163 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14257577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10641382 [patent_doc_number] => 09358232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Methods for treating cancer using TOR kinase inhibitor combination therapy' [patent_app_type] => utility [patent_app_number] => 14/254010 [patent_app_country] => US [patent_app_date] => 2014-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34228 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14254010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10705389 [patent_doc_number] => 20160051536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'COMPOSITIONS TO ALLEVIATE PRESYSTEMIC METABOLISM OF OPIOIDS' [patent_app_type] => utility [patent_app_number] => 14/781683 [patent_app_country] => US [patent_app_date] => 2014-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9395 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685271 [patent_doc_number] => 20140242035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/245668 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16989 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15724207 [patent_doc_number] => 10610517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-07 [patent_title] => Compositions and methods for treating neoplastic diseases [patent_app_type] => utility [patent_app_number] => 14/224965 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 12631 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14224965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739441 [patent_doc_number] => 20140275160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 14/213940 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17502 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684258 [patent_doc_number] => 20160030403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'Novel Dosing Regimens of Celgosivir for the Treatment of Dengue' [patent_app_type] => utility [patent_app_number] => 14/772873 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15942 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11183661 [patent_doc_number] => 09415043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Combination therapy' [patent_app_type] => utility [patent_app_number] => 14/213961 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18956 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700469 [patent_doc_number] => 20160046617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 14/776016 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33052 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692309 [patent_doc_number] => 20160038456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'REGULATION OF CANCER USING NATURAL COMPOUNDS AND/OR DIET' [patent_app_type] => utility [patent_app_number] => 14/775751 [patent_app_country] => US [patent_app_date] => 2014-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 20860 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720996 [patent_doc_number] => 20140256698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'CATHEPSIN INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/205087 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12015 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739547 [patent_doc_number] => 20140275266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'PROSTANOID RECEPTOR AGONIST COMPOUNDS AND METHODS OF USE FOR SAME' [patent_app_type] => utility [patent_app_number] => 14/204845 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8314 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739447 [patent_doc_number] => 20140275166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'SPINTRAPS AND SPIN LABELS AND THEIR HYDROXYLAMINES FOR PERI- AND POST-MENOPAUSAL SYNDROME' [patent_app_type] => utility [patent_app_number] => 14/197524 [patent_app_country] => US [patent_app_date] => 2014-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3773 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197524 [rel_patent_id] =>[rel_patent_doc_number] =>)